Adaptive Biotechnologies Corp vs Bath & Body Works Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.05B), while Bath & Body Works Inc trades at $18.9 (market cap $3.89B). The key difference: Adaptive Biotechnologies Corp and Bath & Body Works Inc are close in size by market cap, and Bath & Body Works Inc pays a 4.14% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | BBWI | |
|---|---|---|
Market Cap | $4.05B | $3.89B |
Sector | Health | Consumer Cyclical |
52-Week High | $25.45 | $31.87 |
52-Week Low | $12.30 | $14.85 |
Enterprise Value | $4.12B | $7.79B |
Dividend Yield | — | 4.14% |
Trailing returns across standard periods
Latest headlines on both assets
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with less than 5% of sales from international markets in fiscal 2021. For fiscal 2021, 72% of sales stemmed from the brick-and-mortar network (which is composed of more than 1,700 retail stores), up from 65% in 2020, as consumer shopping patterns began to return to normal. Future growth is expected from store reformatting, digital and international channels, as well as new category expansion.
Read more on BBWI →